Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129017) titled 'Study on the Cut-off Point of Glycated Hemoglobin A1c for the Diagnosis of Diabetes in the Chinese Population' on July 29.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Zhongda Hospital, Affiliated to Southeast University
Condition:
diabetes mellitus
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-07-31
Target Sample Size: Case group:7000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=318312
Published by HT Digital Content Services with permission from Health Daily Digest....